BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Z, Qi J, Lim CW, Kim JW, Kim B. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro. Toxicology 2020;444:152579. [PMID: 32905826 DOI: 10.1016/j.tox.2020.152579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hang W, Shu H, Wen Z, Liu J, Jin Z, Shi Z, Chen C, Wang DW. N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function. Front Pharmacol 2021;12:636204. [PMID: 34588976 DOI: 10.3389/fphar.2021.636204] [Reference Citation Analysis]
2 Rehman R, Tar L, Olamide AJ, Li Z, Kassubek J, Böckers T, Weishaupt J, Ludolph A, Wiesner D, Roselli F. Acute TBK1/IKK-ε Inhibition Enhances the Generation of Disease-Associated Microglia-Like Phenotype Upon Cortical Stab-Wound Injury. Front Aging Neurosci 2021;13:684171. [PMID: 34326766 DOI: 10.3389/fnagi.2021.684171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Q, Liu Y, Xia X, Sun H, Gao J, Ren Q, Zhou T, Ma C, Xia J, Yin C. Activation of macrophage TBK1-HIF-1α-mediated IL-17/IL-10 signaling by hyperglycemia aggravates the complexity of coronary atherosclerosis: An in vivo and in vitro study. FASEB J 2021;35:e21609. [PMID: 33908659 DOI: 10.1096/fj.202100086RR] [Reference Citation Analysis]
4 Chen D, Du K, Niu X, Zhang H, Zhang X, Tang Y, Zhao J. Development and validation of LC-MS/MS method for amlexanox in rat plasma and its application in preclinical pharmacokinetics. Biomed Chromatogr 2021;:e5288. [PMID: 34842293 DOI: 10.1002/bmc.5288] [Reference Citation Analysis]
5 Pelechá M, Villanueva-bádenas E, Timor-lópez E, Donato MT, Tolosa L. Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models. Antioxidants 2022;11:86. [DOI: 10.3390/antiox11010086] [Reference Citation Analysis]
6 Wang C, Ma C, Gong L, Guo Y, Fu K, Zhang Y, Zhou H, Li Y. Macrophage Polarization and Its Role in Liver Disease. Front Immunol 2021;12:803037. [PMID: 34970275 DOI: 10.3389/fimmu.2021.803037] [Reference Citation Analysis]
7 Zheng Y, Fang D, Huang C, Zhao L, Gan L, Chen Y, Liu F. Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease. Front Pharmacol 2022;12:816032. [DOI: 10.3389/fphar.2021.816032] [Reference Citation Analysis]